NNMT-driven metabolic reprogramming creates a NAMPT druggable vulnerability and reveals liquid biopsy biomarkers for TKI resistance in EGFR-mutant NSCLC

  1. Pulido,I.
  2. García-Cañaveras,J.C.
  3. Rodríguez,M.L.
  4. Becker,J.H.
  5. López,A.
  6. Aupí,M.
  7. Aparisi,S.
  8. Chuliá-Peris,L.
  9. Tamayo-Torres,E.
  10. Carreres-Rey,C.
  11. Alcácer Fernández-Coronado,J.
  12. Benet,M.
  13. Montero,S.
  14. Mena,S.
  15. Sandoval,J.
  16. Pereda,J.
  17. Alcácer,J.
  18. Calabuig-Fariñas,S.
  19. Jantus-Lewintre,E.
  20. Cremades,A.
  21. Galbis-Caravajal,J.M.
  22. Martín-Martorell,P.
  23. Insa,A.
  24. Massad,M.G.
  25. Juan-Vidal,O.
  26. Lahoz,A.
  27. Shimamura,T.
  28. Carretero,J.
  29. Show all authors +
Journal:
Cancer Letters

ISSN: 1872-7980,  0304-3835

Year of publication: 2025

Volume: 633

Type: Article

DOI: 10.1016/J.CANLET.2025.218032 GOOGLE SCHOLAR lock_openOpen access editor
Data source: Scopus